HORIZON PHARMA BUYS RAPTOR FOR $800 MILLION

Horizon Pharma said Monday it is acquiring Raptor Pharmaceutical for $800 million. The deal, due to close in the fourth quarter, will bump up Horizon’s portfolio of drugs for rare diseases. Raptor shares soared 20.5% to $8.98. Horizon was up 9.4% to $18.89.